23rd Jun 2020 11:38
|
| ||||
|
| ||||
| |||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||
|
| ||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | Evgen Pharma plc | ||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | √
| ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| ||||
An event changing the breakdown of voting rights |
| ||||
Other (please specify): | change in percentage of voting rights arising upon a new issue of shares by the issuer |
| |||
3. Full name of person(s) subject to thenotification obligation: iii | Enterprise Ventures Limited | ||||
4. Full name of shareholder(s) (if different from 3.):iv | RisingStars Growth Fund II LP | ||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v | 19th June 2020 | ||||
6. Date on which issuer notified: | 23rd June 2020 | ||||
7. Threshold(s) that is/are crossed orreached: vi, vii | 6%/5%/4% | ||||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | ||||||||||||
Direct | Direct xi | Indirecti | Direct | Indirect | ||||||||||||
GB00BSVYN304 | 8,799,485 | 8,799,485 | 4,419,268 | 4,419,268 | Nil | 3.33 | Nil | |||||||||
| ||||||||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | ||||||||||||
None |
|
|
|
| ||||||||||||
| ||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to
| % of voting rights xix, xx
| |||||||||||
None |
|
|
|
| Nominal | Delta | ||||||||||
|
| |||||||||||||||
| ||||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
4,419,268 | 3.33% | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
| ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: |
| |
11. Number of voting rights proxy holder will ceaseto hold: |
| |
12. Date on which proxy holder will cease to holdvoting rights: |
| |
| ||
13. Additional information: |
| |
14. Contact name: | Enterprise Ventures Limited | |
15. Contact telephone number: | 01772 270 570 | |
Related Shares:
EVG.L